March 16, 2021
Novartis Pharma and Meiji Seika Pharma said on March 12 that they will terminate their sales collaboration and copromotion deal in Japan for the COPD drugs Ultibro (indacaterol + glycopyrronium) and Seebri (glycopyrronium) at the end of this month. Currently,...read more